We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic const... Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities. Show more
– First prospective trial of a glucagon-like peptide (GLP-2) analog in SR GI aGVHD – – Results up to Day 91 show that apraglutide in SR GI aGVHD was well-tolerated with an acceptable safety...
– Apraglutide met the primary endpoint of relative change from baseline in actual weekly parenteral support (PS) volume at week 24, driven by both stoma and colon-in-continuity populations – –...
– Apraglutide nutritional data from STARS Nutrition Phase 2 study in adult patients who have short bowel syndrome with intestinal failure and colon-in-continuity will be highlighted in an oral...
– LINZESS® (Iinaclotide) 2023 U.S. net sales of $1.1 billion, an increase of 7% year-over-year, driven by EUTRx prescription demand growth of 10% year-over-year – – 2023 Ironwood revenue of $443...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.43 | 5.62091503268 | 7.65 | 8.355 | 7.53 | 2726548 | 7.96409014 | CS |
4 | -0.62 | -7.12643678161 | 8.7 | 9.005 | 7.53 | 2531615 | 8.05434268 | CS |
12 | -6.18 | -43.3380084151 | 14.26 | 15.7 | 7.53 | 4687289 | 10.15765295 | CS |
26 | -1.07 | -11.693989071 | 9.15 | 15.7 | 7.53 | 3548138 | 10.59152874 | CS |
52 | -2.49 | -23.5572374645 | 10.57 | 15.7 | 7.53 | 2939458 | 10.34385691 | CS |
156 | -3.04 | -27.3381294964 | 11.12 | 15.7 | 7.53 | 2495510 | 11.13503554 | CS |
260 | -3.85 | -32.2715842414 | 11.93 | 15.7 | 7.53 | 2220347 | 10.93899052 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions